RTN4 and myeloid sarcoma: Interestingly, administration of exogenous anti-RTN4A antibodies protected against demyelination in the experimental autoimmune encephalomyelitis (EAE) mouse model of MS, inasmuch as it suppressed inflammatory responses in these animals (Karnezis et al. 2004).